NO164546C - 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse. - Google Patents

6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse.

Info

Publication number
NO164546C
NO164546C NO850224A NO850224A NO164546C NO 164546 C NO164546 C NO 164546C NO 850224 A NO850224 A NO 850224A NO 850224 A NO850224 A NO 850224A NO 164546 C NO164546 C NO 164546C
Authority
NO
Norway
Prior art keywords
carbolactones
pregn
oxo
methylene
ethylene
Prior art date
Application number
NO850224A
Other languages
English (en)
Norwegian (no)
Other versions
NO164546B (no
NO850224L (no
Inventor
Klaus Nickisch
Dieter Bittler
Henry Laurent
Rudolf Wiechert
Sybille Beier
Walter Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO850224L publication Critical patent/NO850224L/no
Priority to NO890473A priority Critical patent/NO164244C/no
Publication of NO164546B publication Critical patent/NO164546B/no
Publication of NO164546C publication Critical patent/NO164546C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C07J53/008—3 membered carbocyclic rings in position 15/16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
NO850224A 1984-01-20 1985-01-18 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse. NO164546C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO890473A NO164244C (no) 1984-01-20 1989-02-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17- carbolactoner.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843402329 DE3402329A1 (de) 1984-01-20 1984-01-20 6,6-ethylen-15,16-methylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate

Publications (3)

Publication Number Publication Date
NO850224L NO850224L (no) 1985-07-22
NO164546B NO164546B (no) 1990-07-09
NO164546C true NO164546C (no) 1990-10-17

Family

ID=6225757

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850224A NO164546C (no) 1984-01-20 1985-01-18 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse.

Country Status (18)

Country Link
US (1) US4584288A (hu)
EP (1) EP0150157B1 (hu)
JP (1) JPS60161997A (hu)
AT (1) ATE35995T1 (hu)
AU (1) AU568715B2 (hu)
CA (1) CA1267888A (hu)
DD (1) DD232281A5 (hu)
DE (2) DE3402329A1 (hu)
DK (1) DK164326C (hu)
ES (1) ES8605535A1 (hu)
FI (1) FI82252C (hu)
GR (1) GR850138B (hu)
HU (1) HU192291B (hu)
IE (1) IE57837B1 (hu)
IL (1) IL74066A (hu)
NO (1) NO164546C (hu)
PT (1) PT79839B (hu)
ZA (1) ZA85441B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615376A1 (de) * 1986-05-07 1987-11-12 Schering Ag 2,2;6,6-diethylen-3-oxo-17(alpha)-pregn-4-en-21,17-carbolactone, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3916112A1 (de) * 1989-05-16 1990-11-22 Schering Ag Dihydrospirorenon als antiandrogen
DE102004063864A1 (de) * 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
US8445469B2 (en) * 2004-12-30 2013-05-21 Bayer Intellectual Property Gmbh 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
DE102006030416A1 (de) * 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-Methyl-19-nor-androst-4-en-17,17-spiroether (18-Methyl-19-nor-20-spirox-4-en-3-one) sowie diese enthaltende pharmazeutische Präparate
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027635A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063500A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-(1'-Propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063498A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063501A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15, 16-Methylen-17-hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063495A1 (de) * 2007-12-29 2009-09-17 Bayer Schering Pharma Aktiengesellschaft 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel
DE102007063499A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft Steroid-17,17-Lactol-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063503A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-19-nor-21-carbonsäure-Steroid y-Lacton-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007063496A1 (de) 2007-12-29 2009-07-02 Bayer Schering Pharma Aktiengesellschaft 15,16-Methylen-17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-on-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
EP2265629B1 (en) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylene-17 carbolactones and related uses
WO2010068500A2 (en) * 2008-11-25 2010-06-17 Evestra, Inc. PROGESTATIONAL 3-(6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-ENE-17a -YL) PROPIONIC ACID g-LACTONES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422097A (en) * 1965-08-27 1969-01-14 Smithkline Corp 6,6-ethylene spirolactones
DE2652761C2 (de) * 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3227598A1 (de) * 1982-07-22 1984-01-26 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-acylthio-15.16-methylen-3-oxo-17(alpha)-pregna-1.4-dien-21,17-carbolactone, verfahren zu ihrer herstellung und verwendung als arzneimittel
DE3234972A1 (de) * 1982-09-17 1984-03-22 Schering AG, 1000 Berlin und 4709 Bergkamen 7(alpha)-alkyl-17(alpha)-pregn-4-en-21.17-carbolactone und -21-carbonsaeuresalze sowie verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
DK164326B (da) 1992-06-09
ATE35995T1 (de) 1988-08-15
FI850151L (fi) 1985-07-21
DE3563970D1 (en) 1988-09-01
ES8605535A1 (es) 1986-04-01
JPH0564638B2 (hu) 1993-09-16
CA1267888A (en) 1990-04-17
IE57837B1 (en) 1993-04-21
AU568715B2 (en) 1988-01-07
PT79839A (en) 1985-02-01
PT79839B (en) 1986-10-23
EP0150157A2 (de) 1985-07-31
HUT37631A (en) 1986-01-23
DE3402329A1 (de) 1985-08-01
EP0150157B1 (de) 1988-07-27
ES539683A0 (es) 1986-04-01
US4584288A (en) 1986-04-22
FI82252B (fi) 1990-10-31
DK164326C (da) 1992-11-02
JPS60161997A (ja) 1985-08-23
ZA85441B (en) 1985-09-25
DK15385D0 (da) 1985-01-11
DD232281A5 (de) 1986-01-22
IL74066A (en) 1988-07-31
GR850138B (hu) 1985-05-13
IL74066A0 (en) 1985-04-30
HU192291B (en) 1987-05-28
EP0150157A3 (en) 1985-08-28
FI850151A0 (fi) 1985-01-14
FI82252C (fi) 1991-02-11
DK15385A (da) 1985-07-21
IE850112L (en) 1985-07-20
NO164546B (no) 1990-07-09
NO850224L (no) 1985-07-22
AU3791285A (en) 1985-08-01

Similar Documents

Publication Publication Date Title
NO161498C (no) 11beta-aryl-oestradiener og antikonsepsjonsmidler inneholdende disse.
NO164546C (no) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, og antikonsepsjonsmidler inneholdende disse.
AU566960B2 (en) 7-aminoazolo (1,5-alpha) pyrimidines
UA5953A1 (uk) Спосіб отримання похідних сульфонілмочевин
FI860285A0 (fi) 6-tioxantinderivat.
ES2004386A6 (es) Un procedimiento para producir un nuevo derivado de difluorohalometoxifenilo
IE871867L (en) Solutions of oxazaphosphorins
ES8701151A1 (es) Un procedimiento para la produccion de derivados de benzoilurea.
NO881688D0 (no) 14,17beta-ethamo-14beta-oestratriener og oestrateraener, fremgangsmaater for fremstilling av disse og farmasoeytiske preparater inneholdende disse.
JPS57149266A (en) Immunostimulant novel bis- and polydisulfides
IE822987L (en) Fluorophenoxybenzylesters
ES8606868A1 (es) Procedimiento para la obtencion de derivados de la 1,4-dihi-dro-piridina